You are here

Sandoz

Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi

Pharmaceutical Business Review

Wed, 08/14/19 - 11:13 am

Enbrel ruling lifts Amgen shares

BioCentury

Sat, 08/10/19 - 02:02 pm

Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis

Pharmaceutical Business Review

Tue, 07/23/19 - 10:03 am

clinical trials

Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts

Fierce Pharma

Fri, 07/19/19 - 10:47 am

Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap

Fierce Pharma

Wed, 07/10/19 - 11:34 am

Adamis Pharmaceuticals

Sandoz launches oncology generic gefitinib in 13 EU countries

Pharmaceutical Business Review

Wed, 07/3/19 - 09:57 am

metastatic non-small cell lung cancer

Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement

Fierce Pharma

Wed, 06/19/19 - 10:57 pm

Novartis chief Vas Narasimhan wants you to know about the '25-plus’ blockbusters he has in the pipeline

Endpoints

Thu, 05/23/19 - 12:46 pm

Novartis' Sandoz does digital from back office to 'not just apps' therapeutics

Fierce Pharma

Tue, 05/14/19 - 05:04 pm

Novartis vows to fight U.S. price-fixing claims against Sandoz unit

Yahoo/Reuters

Mon, 05/13/19 - 09:24 am

Novartis Poaches GSK Veteran as New Sandoz CEO

BioSpace

Wed, 04/24/19 - 11:48 am

United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug

BioSpace

Fri, 04/19/19 - 05:53 pm

United Therapeutics

Sandoz resubmission puts Amgen's Neulasta at further risk of competition

Biopharma Dive

Wed, 04/3/19 - 09:31 pm

CEO of Novartis’ generics unit quits, sparking sale speculation

Pharmaforum

Thu, 03/14/19 - 10:06 am

Richard Francis

Indivior introduces generic version of Suboxone opioid drug in US

Pharmaceutical Business Review

Thu, 02/21/19 - 09:56 am

‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts

Fierce Pharma

Fri, 02/1/19 - 10:33 pm

drug manufacturing

Novartis plots new course for Sandoz

BioCentury

Wed, 01/30/19 - 11:43 pm

UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing

Fierce Pharma

Tue, 01/22/19 - 11:48 am

UnitedHealthcare

Teva Pharmaceuticals

Par Pharmaceutical

Taro Pharmaceuticals

Sandoz launches EpiPen rival at $250 per two-pack

BioPharma Dive

Fri, 01/18/19 - 09:21 pm

Adamis stock surges on release of EpiPen alternative

Marketwatch

Thu, 01/17/19 - 09:34 am

Pages